CPI-444
Name
CPI-444
Target
Category
Small-molecule
Tumor Types
Renal Cell Cancer
Primary Reference
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
Cancer Discov. 2020 Jan;10(1):40-53
Structure